Product Images Risedronate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Risedronate Sodium NDC 59762-0405 by Greenstone Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The chemical structure of Risedronate Sodium hemi-pentahydrate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Risedronate Sodium for oral administration contains the equivalent of 5, 30, 35, 75, or 150 mg of anhydrous Risedronate Sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for Risedronate Sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of Risedronate Sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monoSodium salt. - risedronate sodium tablets 01

Figure 1 - risedronate sodium tablets 02

This is a chart showing the cumulative incidence of nonvertebral osteoporosis-related fractures over a period of 3 years for patients receiving either a placebo or risedronate sodium 5mg. The fractures are presented by location in the body such as leg, wrist, humerus, hip, pelvis, and clavicle.*

Figure 2 - risedronate sodium tablets 03

The given text represents a figure (Figure 2) depicting a "Change in BMD from Baseline" in a "2-Year Prevention Study". The study involved two treatment groups- Placebo and Risedronate Sodium 5mg with 103 and 101 participants, respectively. It shows the percentage change in Bone Mineral Density (BMD) measured at Lumbar Spine, Femoral Neck, and Femoral Trochanter. However, the numerical values seem to be corrupt or unreadable.*

Figure 3 - risedronate sodium tablets 04

This is a figure showing the change in bone mineral density (BMD) from baseline for patients who recently started glucocorticoid therapy. The BMD is represented in terms of mean percentage change along with standard error (SE). The figure shows the results for placebo, risedronate sodium 5 mg, and three other treatment groups. The treatment groups are labeled as Lo (Lumbar), an (neck), and eS (trochanter). The sample sizes (n) for each treatment group are also mentioned.*

Figure 4 - risedronate sodium tablets 05

The text appears to be an output of a table showing changes in Bone Mineral Density (BMD) from baseline for patients on long-term glucocorticoid therapy. It shows the BMD mean percentage change and standard error values for lumbar spine, femoral neck, and trochanter at different stages of the therapy for a group of patients who took either placebo or risedronate sodium 5 mg.*

Figure 5 - risedronate sodium tablets 06

Figure 6 - risedronate sodium tablets 07

This is a graph showing the mean percentage change from baseline in serum alkaline phosphatase excess by visit for two different treatments - DIDRONEL 400mg and Risedronate Sodium 30mg. It includes follow-up and extended follow-up visits up to 600 days.*

Greenstone - risedronate sodium tablets 08

The Greenstone® brand is distributed by Greenstone LLC located in Peapack, NJ 07977.*

NDC 59762-0405-4risedronate sodium tablets35 mgOnce-a-week4 tabletsRx only - risedronate sodium tablets 0a

This is a medication called Risedronate Sodium, available in tablet form at a strength of 35mg. The package seems to contain 4 tablets and may have been supplied by a company called "W & weoksuppy".*

NDC 59762-0405-4risedronate sodium tablets35 mgOnce-a-week4 tabletsRx only - risedronate sodium tablets 0b

This appears to be a list of medications, but the text is not fully legible due to errors. It is not possible to generate a useful description with this text.*

NDC 59762-0405-5risedronate sodium tablets35 mg12 week supply12 - risedronate sodium tabletsRx only - risedronate sodium tablets 0c

The text is not readable because of errors.*

NDC 59762-0405-5risedronate sodium tablets35 mg12 week supply12 - risedronate sodium tabletsRx only - risedronate sodium tablets 0d

NDC 59762-0406-1risedronate sodium tablets150 mgONE month pack(1 tablet)Rx only - risedronate sodium tablets 0e

This appears to be a label for medication called "risedronate sodium tablets" made by Greenstones brand. It is not available.*

NDC 59762-0406-1risedronate sodium tablets150 mgONE month pack(1 tablet)Rx only - risedronate sodium tablets 0f

The text is not-available as it consists of incomplete and unclear words/letters.*

NDC 59762-0406-3risedronate sodium tablets150 mg3 month packRx only - risedronate sodium tablets 10

Greenston's brand of risedronate sodium tablets is featured in the text along with some illegible characters.*

NDC 59762-0406-3risedronate sodium tablets150 mg3 month packRx only - risedronate sodium tablets 11

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.